Tecan successfully completes the acquisition of NuGEN Technologies
03 Septiembre 2018 - 12:15AM
Tecan Group AG / Tecan successfully completes the acquisition of
NuGEN Technologies . Processed and transmitted by Nasdaq Corporate
Solutions. The issuer is solely responsible for the content of this
announcement.
Männedorf, Switzerland, September 3, 2018 - The Tecan
Group (SIX Swiss Exchange: TECN) announced today that it has
successfully completed the acquisition of NuGEN Technologies, Inc.
(NuGEN) on August 31, 2018. On August 16, 2018, Tecan announced the
acquisition of US-based NuGEN to further expand Tecan's dedicated
solutions offering into the new market segment of next-generation
sequencing (NGS) reagents and thus further increasing Tecan's
overall recurring revenues. NuGEN is a leading provider for
innovative NGS kits and genomic sample preparation solutions for
the fastest growing field within the genomics area.
From September 1, 2018, NuGEN will be included in the consolidated
financial statements of the Tecan Group as a part of the Life
Sciences Business segment.
Additional information
can be found on the NuGEN webpage:
www.nugen.com
About
Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions in biopharmaceuticals, forensics and
clinical diagnostics. The company specializes in the development,
production and distribution of automated workflow solutions for
laboratories in the life sciences sector. Its clients include
pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original
equipment manufacturer (OEM), Tecan is also a leader in developing
and manufacturing OEM instruments and components that are then
distributed by partner companies. Founded in Switzerland in 1980,
the company has manufacturing, research and development sites in
both Europe and North America and maintains a sales and service
network in 52 countries. In 2017, Tecan generated sales of
CHF 548 million (USD 560 million;
EUR 494 million). Registered shares of Tecan Group are
traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For
further information:
Tecan
Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Press release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Tecan Group AG via Globenewswire
--- End of Message ---
Tecan Group AG
Seestrasse 103 Maennedorf Switzerland
ISIN: CH0012100191;